Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials

Alkermes is committed to researching and developing potential new cancer treatment options that may help address unmet patient needs. Clinical trials are an important step in evaluating the safety and efficacy of potential treatments. Learn more about the ongoing clinical trial program for our investigational immuno-oncology candidate: https://bit.ly/3pl8pkG

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com